Rob Rogers and Louisa Holland have been promoted to co-CEO of Sudler and Hennessey's operations in the Americas.

Although four million people have tried GlaxoSmithKline's OTC weight loss drug Alli during its first year on the market, preliminary sales figures are "pretty underwhelming," one analyst tells the Associated Press.

The Hal Lewis Group has promoted Morgan Shinick from senior account executive to account supervisor.

Shire received a warning letter from the FDA's Division of Drug Marketing, Advertising and Communications (DDMAC) asking the drugmaker to halt distribution of specific professional marketing materials for its end stage renal disease treatment Fosrenol (lanthanum carbonate).

Doctors rate Merck's ePromotion efforts as tops in the industry, according to pharmaceutical marketing data firm Verispan.

Sanofi-Aventis has teamed with Eli Lilly in a collaboration to market erectile-dysfunction drug Cialis (tadalafil) to US urologists.

Shire has entered a three-year deal with TAP Pharmaceutical to co-promote ulcerative colitis treatment, Shire's Lialda, in the US.

Eli Lilly has denied the assertions of a recent New York Times article alleging that incoming CEO John Lechleiter encouraged off-label promotion of the company's embattled schizophrenia treatment Zyprexa (olanzapine) in an e-mail he sent in 2003.

Endo Pharmaceuticals announced that David Holveck has been named president, CEO and a director of the company, effective April 1, 2008.

Endo Pharmaceuticals has entered into a licensing agreement with Novartis to obtain the exclusive US marketing rights for the prescription medicine Voltaren Gel (diclofenac sodium topical gel) 1%.